SK biotek Ireland an SK pharmteco company
Declan Hannigan possesses extensive experience in operations and business strategy, currently serving as the Director of Business Strategy & OpEx at SK biotek Ireland Limited since January 2018, having previously held roles as Operations Director and Operations Lead. Prior to this, Declan worked at Bristol Myers Squibb from June 2004 to December 2017 in various operational roles, including Operations Lead and Maintenance Manager, and began professional career as a Maintenance Engineer at Irish Cement Limited from September 2001 to June 2004. Academic qualifications include a Degree in Mechanical Engineering from University College Dublin, a Diploma in Industrial Safety from University College Dublin, and a Diploma in Industrial Relations from Technological University Dublin.
This person is not in any teams
SK biotek Ireland an SK pharmteco company
***This page has moved and is no longer active. Please follow us @SK pharmteco for all company news and updates.*** SK biotek Ireland, an SK pharmteco company, is a contract development and manufacturing organization with almost 60 years of active pharmaceutical ingredients manufacturing experience. SK biotek Ireland is the most recent addition to the SK Group. Headquartered in Seoul, Korea, SK Group is ranked in the Top 100* on the Fortune Global 500 list; creating value by taking the initiative in the field of energy and chemicals, information, telecommunications, semiconductors; employing over 109,000 associates globally with annual revenue of US$100 billion. SK biotek Ireland, based in Swords, Co. Dublin, has over 300 associates on campus, comprising of scientists, chemists, engineers, quality professionals carrying out research, development, manufacturing and marketing roles. *2020 Fortune 500 List